liranaftate (Compound)

Synonyms:Liranaftate, 88678-31-3, Piritetrate, Liranaftate [INN], Zefnart, M-732, Piritetrate;M-732, O-(5,6,7,8-tetrahydronaphthalen-2-yl) N-(6-methoxypyridin-2-yl)-N-methylcarbamothioate, DTXSID6046470, 5253IGO5X3, O-(5,6,7,8,-Tetrahydro-2-naphthyl) 6-methoxy-N-methylthio-2-pyridinecarbamate, O-(5,6,7,8-tetrahydronaphthalen-2-yl) (6-methoxypyridin-2-yl)(methyl)carbamothioate, NCGC00164601-01, Liranaftato, Liranaftatum, DTXCID4026470, Liranaftatum [INN-Latin], Liranaftato [INN-Spanish], O-(5,6,7,8-TETRAHYDRO-2-NAPHTHYL) N-(6-METHOXY-2-PYRIDYL)-N-METHYLTHIOCARBAMATE, CAS-88678-31-3, Piritetate, UNII-5253IGO5X3, Zefnart (TN), M-732; Piritetrate, Liranaftate (JAN/INN), LIRANAFTATE [MI], LIRANAFTATE [JAN], LIRANAFTATE [MART.], LIRANAFTATE [WHO-DD], MLS006011138, SCHEMBL180466, CHEMBL1591365, CHEBI:31775, GLXC-25562, HMS3714A16, ACT06298, BCP11494, HY-B0348, O-tetralin-6-yl N-(6-methoxy-2-pyridyl)-N-methyl-carbamothioate, Tox21 112223, Tox21_112223, MFCD00865576, s1997, AKOS015852015, Tox21_112223_1, AB07498, AC-3400, CCG-220727, NCGC00164601-02, NCGC00164601-03, AS-56279, Carbamothioic acid, (6-methoxy-2-pyridinyl)methyl-, O-(5,6,7,8-tetrahydro-2-naphthalenyl) ester, SMR002204143, FT-0630959, L0301, D01550, AB01566849_01, SR-01000872646, SR-01000872646-1, Q27167100, (6-METHOXY-2-PYRIDINYL)-METHYLCARBAMOTHIOIC ACID, O-(5,6,7,8-Tetrahydronaphthalen-2-yl) (6-methoxypyridin-2-yl)methylthiocarbamate, O-5,6,7,8-tetrahydronaphthalen-2-yl 6-methoxypyridin-2-yl(methyl)carbamothioate, (6-Methoxypyridin-2-yl)(methyl)carbamothioic Acid O-(5,6,7,8-Tetrahydronaphthalen-2-yl) Ester

Pubchem:PUBCHEM:3936

Id:7ef83d5d-3301-56c5-aacf-c37c364a111f

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View liranaftate's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for liranaftate.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with liranaftate.

Results found

Linked to

	Label	Description
	BRD-K35775715-001-03-1 Substance (Entity type)	A Substance
	DCSTRUCT ID 01586 Collection (Entity type)	DrugPage Collection: (DrugCentralID:01586; PubChem_CID:3936, FILE=drugcentral_drug_01586.json)
	liranaftate negatively regulates C1orf115 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	liranaftate negatively regulates SCGB1D2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	liranaftate positively regulates RGS3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	SA-1457472 in similarity relationship with liranaftate Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	liranaftate positively regulates ID3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	liranaftate negatively regulates SYNM Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	liranaftate positively regulates UPP1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	liranaftate negatively regulates COBL Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS